Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids (IPG30)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids.
As part of the NICE's work programme, the current guidance was considered for review in May 2009 but did not meet the review criteria as set out in the IP process guide. The guidance below therefore remains current.
This procedure is used to treat uterine fibroids (also known as uterine leiomyomas or uterine myomas).
Symptoms caused by fibroids include abnormal bleeding, pelvic pressure and pain, and reproductive problems. Fibroids are common and are the most frequent reason for a woman to have a hysterectomy.
Magnetic resonance (MR) image guided percutaneous laser ablation is a minimally invasive technique for the treatment of uterine fibroids. Patients are given intravenous sedation and analgesia and a catheter is placed in the bladder.
Under MR guidance needles are inserted into the centre of the targeted uterine fibroid through an area of skin that has been anaesthetised. Bare laser fibres are inserted down the centre of each of the needles into the targeted fibroid. Laser energy is then used to destroy the fibroid.
A thermal mapping sequence is then used to depict the extent of the heated tissue in the target area as the procedure is carried out. Each procedure may involve up to three successive power applications in an overlapping manner to cover as much of the target fibroid as possible whilst monitoring the exact site of heat deposition with thermal mapping.
Q20.8 Other specified other operations on uterus
Y08.4 Laser destruction of lesion of organ NOC
Y53.7 Approach to organ under magnetic resonance imaging control
In addition the ICD-10 code from category D25.- Leiomyoma of uterus would be recorded.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG30 Magnetic resonance image-guided percutaneous laser ablation for uterine fibroids: guidance (web format)
- IPG30 Magnetic resonance image-guided percutaneous laser ablation for uterine fibroids: guidance
- IPG30 Magnetic resonance image-guided percutaneous laser ablation for uterine fibroids: understanding NICE guidance
- IPG30 Magnetic resonance image-guided percutaneous laser ablation for uterine fibroids: distribution list
- Consent - procedures for which the benefits and risks are uncertain
- Interventional procedures consultation document - magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids
- Overview of magnetic resonance image-guided percutaneous laser ablation of uterine fibroids
This page was last updated: 08 February 2011
- Web format
- Full Guidance (PDF)
- IPG30 Abladiad laser trwy'r croen wedi'i arwain gan ddelweddau soniaredd magnetig (MR) i drin ffibroidau yn y groth: deall canllawiau NICE
Information for the public
Implementation tools and resources
- None available
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.